Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Sleep Disturbance in Spinal Surgery
NCT06451627Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of postoperative sleep disturbance at 3 days. Started Jun 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06451627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451627.